Lupus & antiphospholipid syndrome

BAFFR expression in circulating T follicular helper (CD4 + CXCR5 + PD-1 + ) and T peripheral helper (CD4 + CXCR5 − PD-1 + ) cells in systemic lupus erythematosus

LupusPublished Cross-sectional study

Authors' conclusion

This study emphasizes the importance of cTfh and Tph cells in SLE pathogenesis.

Study context

Population
Systemic lupus erythematosus (SLE) patients and healthy subjects
Participants
43 vs 12
Exposure
SLE patients vs healthy subjects
  • SLEn = 43
  • Healthy subjects (HS)n = 12reference
Outcome
Association of cTfh (CD4+CXCR5+PD-1+) and Tph (CD4+CXCR5-PD-1+) subpopulations with BAFF system expression and clinical activity in SLE
Methodological detailsflow cytometry, ELISA
  • Flow cytometry
  • ELISA

Main finding

As reported in the abstract

cTfh and Tph cells, BAFF system and disease activity
  • Significantly increased percentage of Circulating T follicular helper (cTfh) and T peripheral helper (Tph) cells in SLE vs HS, higher in clearly active disease
  • Markedly higher IL-21-producing cTfh and Tph cells in SLE vs HS
  • cTfh and Tph cells positively correlated with disease activity in SLE
  • Tph cells negatively correlated with CD19+CXCR5+ B cells and positively with CD19+CXCR5- B cells
  • Low expression of mBAFF, TACI and BCMA on cTfh and Tph cells in SLE and HS
  • Decreased BAFFR on cTfh and Tph cells in clearly active vs mildly active/nonactive SLE

Observational data: associations, not effects.

Further findings

Serum IL-21, CXCL13 and BAFF higher in SLE than HS
CXCL13 correlated with disease activity
Non-significant correlations between T cell subpopulations and IL-21, CXCL13 and BAFF levels

Original publication

BAFFR expression in circulating T follicular helper (CD4 + CXCR5 + PD-1 + ) and T peripheral helper (CD4 + CXCR5 − PD-1 + ) cells in systemic lupus erythematosus. Lupus. Published 17 July 2023. doi:10.1177/09612033231189804

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.